Literature DB >> 16044010

Couples at risk: HIV-1 concordance and discordance among sexual partners receiving voluntary counseling and testing in Uganda.

Samuel S Malamba1, Jonathan H Mermin, Rebecca Bunnell, John Mubangizi, Josephine Kalule, Elizabeth Marum, Dale J Hu, Sam Wangalwa, Dawn Smith, Robert Downing.   

Abstract

OBJECTIVE: To determine correlates of HIV-1 concordance for couples receiving voluntary HIV counseling and testing.
DESIGN: Cross-sectional study of couples receiving voluntary HIV counseling and testing in Kampala, Uganda.
METHODS: An interview and physical examination were conducted for 49 HIV-1-concordant (both partners infected with HIV) and 126 HIV-1-discordant (1 partner infected with HIV and 1 partner HIV negative) couples. Blood samples from all participants were tested for HIV-1 and syphilis serology. CD4 cell count and HIV load were characterized for all HIV-infected persons. Urine samples were tested for Neisseria gonorrhoeae and Chlamydia trachomatis using ligase chain reaction. Associations between couples' HIV status and key sociodemographic, behavioral, and biomedical factors were analyzed.
RESULTS: Men in HIV-concordant couples were more likely than men in HIV-discordant couples to be living together with their sexual partner (odds ratio [OR], 11.3; 95% confidence interval [CI], 2.8-53.7; P=0.004), to be uncircumcised (OR, 4.5; 95% CI, 1.1-18.8; P=0.042), and to have higher HIV loads (OR for each log increase, 3.0; 95% CI, 2.0-4.7; P<0.001). Women in HIV-concordant couples were more likely than women in HIV-discordant couples to be living together with their sexual partner (OR, 19.0; 95% CI, 3.8-84.8), to have an uncircumcised male partner (OR, 6.5; 95% CI, 1.6-26.4), to have had a sexually transmitted disease in the 6 months before enrollment (OR, 1.9; 95% CI, 0.9-4.5), and to have higher HIV loads (OR for each log increase, 2.2; 95% CI, 1.5-3.2).
CONCLUSIONS: Several behavioral and biologic risk factors were associated with HIV concordance for couples. Providing early sexually transmitted disease diagnosis and treatment, antiretroviral therapy, and specially designed counseling to HIV-discordant couples may help prevent HIV transmission in couples where being in a stable sexual relationship is a major risk factor for HIV infection.

Entities:  

Mesh:

Year:  2005        PMID: 16044010

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  25 in total

1.  An integrated approach for antiretroviral adherence and secondary HIV transmission risk-reduction support by nurses in Kenya.

Authors:  Ann E Kurth; Lauren McClelland; George Wanje; Annette E Ghee; Norbert Peshu; Esther Mutunga; Walter Jaoko; Marta Storwick; King K Holmes; Scott McClelland
Journal:  J Assoc Nurses AIDS Care       Date:  2011-07-30       Impact factor: 1.354

2.  Changes in condom use during the first year of HIV treatment in Uganda and the relationship to depression.

Authors:  Glenn J Wagner; Bonnie Ghosh-Dastidar; Mary Ellen Slaughter; Dickens Akena; Noeline Nakasujja; Seggane Musisi
Journal:  Ann Behav Med       Date:  2014-10

Review 3.  Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update.

Authors:  Reuben Granich; Siobhan Crowley; Marco Vitoria; Caoimhe Smyth; James G Kahn; Rod Bennett; Ying-Ru Lo; Yves Souteyrand; Brian Williams
Journal:  Curr Opin HIV AIDS       Date:  2010-07       Impact factor: 4.283

4.  Predicting partner HIV testing and counseling following a partner notification intervention.

Authors:  Lillian B Brown; William C Miller; Gift Kamanga; Jay S Kaufman; Audrey Pettifor; Rosalie C Dominik; Naomi Nyirenda; Pearson Mmodzi; Clement Mapanje; Francis Martinson; Myron S Cohen; Irving F Hoffman
Journal:  AIDS Behav       Date:  2012-07

5.  HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention.

Authors:  Lillian B Brown; William C Miller; Gift Kamanga; Naomi Nyirenda; Pearson Mmodzi; Audrey Pettifor; Rosalie C Dominik; Jay S Kaufman; Clement Mapanje; Francis Martinson; Myron S Cohen; Irving F Hoffman
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04-15       Impact factor: 3.731

6.  Highly active antiretroviral treatment for the prevention of HIV transmission.

Authors:  Reuben Granich; Siobhan Crowley; Marco Vitoria; Ying-Ru Lo; Yves Souteyrand; Christopher Dye; Charlie Gilks; Teguest Guerma; Kevin M De Cock; Brian Williams
Journal:  J Int AIDS Soc       Date:  2010-01-12       Impact factor: 5.396

7.  Men's circumcision status and women's risk of HIV acquisition in Zimbabwe and Uganda.

Authors:  Abigail Norris Turner; Charles S Morrison; Nancy S Padian; Jay S Kaufman; Robert A Salata; Tsungai Chipato; Francis A Mmiro; Roy D Mugerwa; Frieda M Behets; William C Miller
Journal:  AIDS       Date:  2007-08-20       Impact factor: 4.177

8.  Modeling HIV transmission risk among Mozambicans prior to their initiating highly active antiretroviral therapy.

Authors:  C R Pearson; A E Kurth; S Cassels; D P Martin; J M Simoni; P Hoff; E Matediana; S Gloyd
Journal:  AIDS Care       Date:  2007-05

9.  "The Cango Lyec Project - Healing the Elephant": HIV related vulnerabilities of post-conflict affected populations aged 13-49 years living in three Mid-Northern Uganda districts.

Authors:  Samuel S Malamba; Herbert Muyinda; Patricia M Spittal; John P Ekwaru; Noah Kiwanuka; Martin D Ogwang; Patrick Odong; Paul K Kitandwe; Achilles Katamba; Kate Jongbloed; Nelson K Sewankambo; Eugene Kinyanda; Alden Blair; Martin T Schechter
Journal:  BMC Infect Dis       Date:  2016-11-21       Impact factor: 3.090

10.  Persons living with HIV in sero-discordant partnerships experience improved HIV care engagement compared with persons living with HIV in sero-concordant partnerships: a cross-sectional analysis of four African countries.

Authors:  Domonique M Reed; Allahna L Esber; Trevor A Crowell; Kavitha Ganesan; Hannah Kibuuka; Jonah Maswai; John Owuoth; Emmanuel Bahemana; Michael Iroezindu; Julie A Ake; Christina S Polyak
Journal:  AIDS Res Ther       Date:  2021-07-22       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.